<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ketendo</journal-id><journal-title-group><journal-title xml:lang="ru">Клиническая и экспериментальная тиреоидология</journal-title><trans-title-group xml:lang="en"><trans-title>Clinical and experimental thyroidology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-5472</issn><issn pub-type="epub">2310-3787</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/ket2017120-25</article-id><article-id custom-type="elpub" pub-id-type="custom">ketendo-8731</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original Studies</subject></subj-group></article-categories><title-group><article-title>Изучение значимости тиреоглобулина в крови в качестве биомаркера при оценке тяжести йододефицитных состояний в Узбекистане</article-title><trans-title-group xml:lang="en"><trans-title>Evaluating of significance of thyroglobulin (Tg) level in blood as a biomarker of iodine deficiency disorders severity in Uzbekistan</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9115-7833</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Исмаилов</surname><given-names>Сайдиганиходжа Ибрагимович</given-names></name><name name-style="western" xml:lang="en"><surname>Ismailov</surname><given-names>Saydiganikhodja I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><email xlink:type="simple">murodrashitov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9208-0455</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рашитов</surname><given-names>Муроджон Мухамеджанович</given-names></name><name name-style="western" xml:lang="en"><surname>Rashitov</surname><given-names>Murod M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, русский и английский</p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">murodrashitov@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0012-4292</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Алимджанов</surname><given-names>Нусрат Амилджанович</given-names></name><name name-style="western" xml:lang="en"><surname>Alimdjanov</surname><given-names>Nusrat A.</given-names></name></name-alternatives><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">murodrashitov@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4258-3614</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Узбеков</surname><given-names>Камиль Кашафович</given-names></name><name name-style="western" xml:lang="en"><surname>Uzbekov</surname><given-names>Kamil K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н.</p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">murodrashitov@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3918-1374</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ваккасов</surname><given-names>Мухаммаджон Хабибович</given-names></name><name name-style="western" xml:lang="en"><surname>Vakkasov</surname><given-names>Muhammadjon Kh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н.</p></bio><bio xml:lang="en"><p>MD</p></bio><email xlink:type="simple">mvakkasov@inbox.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4307-2317</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Муратов</surname><given-names>Тимур Фахруддинович</given-names></name><name name-style="western" xml:lang="en"><surname>Muratov</surname><given-names>Timur F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н.</p></bio><bio xml:lang="en"><p>MD</p></bio><email xlink:type="simple">murodrashitov@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8010-8083</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Омилджонов</surname><given-names>Муроджон Нусратжанович</given-names></name><name name-style="western" xml:lang="en"><surname>Omildjonov</surname><given-names>Murodjon N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н.</p></bio><bio xml:lang="en"><p>MD</p></bio><email xlink:type="simple">murodrashitov@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>&lt;p&gt;Республиканский специализированный научно-практический медицинский центр эндокринологии Минздрава Республики Узбекистан&lt;/p&gt;</institution><country>Узбекистан</country></aff><aff xml:lang="en"><institution>&lt;p&gt;Republic Specialized Scientific and Practice Medical Center of Endocrinology&lt;/p&gt;</institution><country>Uzbekistan</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>&lt;p&gt;Республиканский специализированный научно-практический медицинский центр эндокринологии&amp;nbsp;Минздрава Республики Узбекистан&lt;/p&gt;</institution><country>Узбекистан</country></aff><aff xml:lang="en"><institution>&lt;p&gt;Republic Specialized Scientific and Practice Medical Center of Endocrinology&lt;/p&gt;</institution><country>Uzbekistan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>07</day><month>07</month><year>2017</year></pub-date><volume>13</volume><issue>1</issue><fpage>20</fpage><lpage>25</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Исмаилов С.И., Рашитов М.М., Алимджанов Н.А., Узбеков К.К., Ваккасов М.Х., Муратов Т.Ф., Омилджонов М.Н., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Исмаилов С.И., Рашитов М.М., Алимджанов Н.А., Узбеков К.К., Ваккасов М.Х., Муратов Т.Ф., Омилджонов М.Н.</copyright-holder><copyright-holder xml:lang="en">Ismailov S.I., Rashitov M.M., Alimdjanov N.A., Uzbekov K.K., Vakkasov M.K., Muratov T.F., Omildjonov M.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.cet-endojournals.ru/jour/article/view/8731">https://www.cet-endojournals.ru/jour/article/view/8731</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Йододефицитные состояния относятся к числу наиболее распространенных неинфекционных заболеваний человека. Известно, что тиреоглобулин в крови является перспективным биомаркером для определения степени выраженности дефицита йода в регионе.</p></sec><sec><title>Цель</title><p>Цель: изучение значимости тиреоглобулина в крови в качестве биомаркера при оценке тяжести йододефицитных состояний в Республике Узбекистан (РУз).</p></sec><sec><title>Методы</title><p>Методы. Нами было изучено значение тиреоглобулина в крови у детей, проживающиx в условиях йододефицита. С этой целью были обследованы 366 детей в возрасте 8–12 лет, из них 163 мальчика и 203 девочки, в городах Бухаре, Фергане, Карши, Хиве, Коканде, Маргилане, Мойнаке и Самарканде. Также определяли йодурию, распространенность диффузного зоба, концентрацию тиреотропного гормона (ТТГ) и свободного тироксина (св.Т4) в крови.</p></sec><sec><title>Результаты</title><p>Результаты. Распространенность зоба у детей 8–12 лет в РУз составила 27% со средним показателем тиреоглобулина в крови 12,8 ± 10,4 нг/мл при медиане йодурии 120,27 мкг/л. При этом ТТГ крови составил 2,75 ± 1,69 мМЕ/л и св.Т4 – 14,48 ± 3,96 пмоль/л. Уровень тиреоглобулина зависел от размера щитовидной железы и у детей без увеличения щитовидной железы составил 11,9 ± 7,9 нг/мл, у детей с диффузным увеличением щитовидной железы – 16,4 ± 10,5 нг/мл (при диффузном зобе 1-й степени – 14,24 ± 13,5 нг/мл и при диффузном зобе 2-й степени – 18,82 ± 18,3 нг/мл).</p></sec><sec><title>Выводы</title><p>Выводы. Наши исследования показали, что даже при медиане йодурии 120,27 мкг/л и среднем показателе тиреоглобулина крови 12,8 ± 10,4 нг/мл у 39% обследованных детей показатель йодурии все еще составляет менее 100 мкг/л.</p></sec></abstract><trans-abstract xml:lang="en"><p>Iodine deficiency has serious adverse effects on growth and development of humans, such as mental impairment. It is known, that thyroglobulin level in blood is promising biomarker that can determine iodine deficiency disorders severity in a given region.</p><sec><title>The Aim of study</title><p>The Aim of study: Evaluating of significance of thyroglobulin level in blood as a biomarker of iodine deficiency disorders severity in Uzbekistan..</p></sec><sec><title>Materials and Methods</title><p>Materials and Methods: We evaluated thyroglobulin level in blood in schoolchildren of Uzbekistan. In this purpose we studied 366 schoolchildren in 8-12 age group, of that 163 boys and 203 girls living in Tashkent city, Fergana, Samarkand, Bukhara, Kashkadarya, Khoresm and Republic of Karakalpakistan. Such parameters as urinary iodine concentration, diffuse goiter plasma TSH, fT4 were analyzed too.</p></sec><sec><title>Results</title><p>Results: Diffuse goiter prevalence was 27 % among children, the overall mean thyroglobulin concentration was 12,8 ± 10.4 ng/ml, the overall median urinary iodine concentration (UIC) was 120.27 μg/L indicating iodine sufficiency. Plasma TSH was 2.75 ± 1.69 mIU/l and plasma fТ4 14.48 ± 3,96 pmol/l.  Thyroglobulin level depended on goiter size, so that in children without goiter (grade 0) mean thyroglobulin concentration was 11,9 ± 7.9 ng/ml, in children with goiter grade 1 mean thyroglobulin concentration was 14,24 ± 13.5 ng/ml and in children with goiter grade 2 mean thyroglobulin concentration was 18,82±18,3 ng/ml. Overall mean thyroglobulin concentration of goitrous children (grade 1 and 2) was 16,4±10,5 ng/ml.</p></sec><sec><title>Conclusions</title><p>Conclusions: Though international studies in school-aged children showed that iodine-sufficient children typically had a median Tg &lt;13 ng/ml, our investigation showed that while study group’s  UIC was 120.27 μg/L and overall mean thyroglobulin concentration was 12,8 ± 10.4 ng/ml, that is equal to median thyroglobulin concentration – 11,73 ng/ml, 39% of children in this group still have UIC below 100 μg/L.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>тиреоглобулин</kwd><kwd>йододефицитные состояния</kwd><kwd>Узбекистан</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Pearce EN, Andersson M, Zimmermann MB. Global iodine nutrition: Where do we stand in 2013? Thyroid. 2013;23(5):523-528. doi: 10.1089/thy.2013.0128.</mixed-citation><mixed-citation xml:lang="en">Pearce EN, Andersson M, Zimmermann MB. Global iodine nutrition: Where do we stand in 2013? Thyroid. 2013;23(5):523-528. doi: 10.1089/thy.2013.0128.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Andersson M, Karumbunathan V, Zimmermann MB. Global iodine status in 2011 and trends over the past decade. J Nutr. 2012;142(4):744-750. doi: 10.3945/jn.111.149393.</mixed-citation><mixed-citation xml:lang="en">Andersson M, Karumbunathan V, Zimmermann MB. Global iodine status in 2011 and trends over the past decade. J Nutr. 2012;142(4):744-750. doi: 10.3945/jn.111.149393.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Guideline: Fortification of Food-Grade Salt with Iodine for the Prevention and Control of Iodine Deficiency Disorders. WHO: Geneva; 2014.</mixed-citation><mixed-citation xml:lang="en">Guideline: Fortification of Food-Grade Salt with Iodine for the Prevention and Control of Iodine Deficiency Disorders. WHO: Geneva; 2014.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Исмаилов С.И., Рашитов М.М. Прогресс в области профилактики йододефицитных заболеваний в Республике Узбекистан (1998–2016) // Клиническая и экспериментальная тиреоидология. – 2016. – Т. 12. – №3. – C. 20–24. [Ismailov SI, Rashitov MM. Progress in the field of iodine deficiency disorders prevention in Republic of Uzbekistan (1998–2016). Clinical and experimental thyroidology. 2016;12(3):20-24. (in Russ.)]. doi: 10.14341/ket2016320-24.</mixed-citation><mixed-citation xml:lang="en">Исмаилов С.И., Рашитов М.М. Прогресс в области профилактики йододефицитных заболеваний в Республике Узбекистан (1998–2016) // Клиническая и экспериментальная тиреоидология. – 2016. – Т. 12. – №3. – C. 20–24. [Ismailov SI, Rashitov MM. Progress in the field of iodine deficiency disorders prevention in Republic of Uzbekistan (1998–2016). Clinical and experimental thyroidology. 2016;12(3):20-24. (in Russ.)]. doi: 10.14341/ket2016320-24.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. Assessment of iodine deficiency disorders and monitoring their elimination: a guide for programme managers. 3rd edition. Geneva, Switzerland: World Health Organization; 2007.</mixed-citation><mixed-citation xml:lang="en">World Health Organization. Assessment of iodine deficiency disorders and monitoring their elimination: a guide for programme managers. 3rd edition. Geneva, Switzerland: World Health Organization; 2007.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ma ZF, Skeaff SA. Thyroglobulin as a biomarker of iodine deficiency: a review. Thyroid. 2014;24(8):1195-1209. doi: 10.1089/thy.2014.0052.</mixed-citation><mixed-citation xml:lang="en">Ma ZF, Skeaff SA. Thyroglobulin as a biomarker of iodine deficiency: a review. Thyroid. 2014;24(8):1195-1209. doi: 10.1089/thy.2014.0052.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zimmermann MB, Aeberli I, Andersson M, et al. Thyroglobulin is a sensitive measure of both deficient and excess iodine intakes in children and indicates no adverse effects on thyroid function in the UIC range of 100-299 mug/L: a UNICEF/ICCIDD study group report. J ClinEndocrinol Metab. 2013;98(3):1271-1280. doi: 10.1210/jc.2012-3952.</mixed-citation><mixed-citation xml:lang="en">Zimmermann MB, Aeberli I, Andersson M, et al. Thyroglobulin is a sensitive measure of both deficient and excess iodine intakes in children and indicates no adverse effects on thyroid function in the UIC range of 100-299 mug/L: a UNICEF/ICCIDD study group report. J ClinEndocrinol Metab. 2013;98(3):1271-1280. doi: 10.1210/jc.2012-3952.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
